Johnson & Johnson Consumer recently announced several executive changes to its Skin Health business.
Duda Kertesz has been named President of U.S. Skin Health at Johnson & Johnson Consumer. Duda is responsible for advancing innovation on the organization’s Skin Health equities including Neutrogena and Aveeno as well as specialty skin care brands such as NeoStrata. Additionally, Duda will continue to oversee the U.S. Baby business, including the Johnson’s, Aveeno Baby and Desitin brands. A seasoned global leader, Duda has extensive experience in shaping business strategy and strengthening brand equity. In her most recent role, Duda served as the President of U.S. Health at Johnson & Johnson Consumer, leading iconic brand equities such as Johnson’s, Listerine, Band-Aid Brand and Neosporin. Duda succeeds Michelle Freyre, who has left Johnson & Johnson Consumer to pursue other opportunities. Duda’s role became effective on July 1, 2019. She is reporting to the President of North America Consumer at Johnson & Johnson Consumer, Kathy Widmer.
Additionally, Deeptha Khanna has been appointed to the newly created position of Global President, Skin Health and the Office of Marketing Value at Johnson & Johnson Consumer. Deeptha is responsible for leading the global portfolio of science-backed skin health brands, including Neutrogena, Aveeno, NeoStrata and Dr. Ci:Labo. She’s also accountable for strengthening the company’s global capabilities in media, content, digital, technology, business and consumer intelligence and consumer care. Most recently, Deeptha served as President of Global Baby Care, where she spearheaded the transformation of the baby care business. In addition to directing the end-to-end reinvention of JOHNSON’S, she led a portfolio-wide expansion in both premium and emerging markets around the world. Deeptha succeeds Sebastien Guillon, who is pursuing other opportunities. Deeptha’s role became effective on July 1. She reports to Thibault Mongon, Worldwide Chairman of Johnson & Johnson Consumer.